Plain-English translation of NCT06877065 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is examining how MRI (magnetic resonance imaging) scans can help doctors better plan and monitor fertility-sparing treatments for women with early-stage cervical cancer. The study looks at both past patient records and new patients to understand how MRI imaging helps identify which women are good candidates for treatments that allow them to preserve their ability to have children. Researchers hope this will improve treatment decisions and help identify warning signs of more aggressive disease.
Many young women diagnosed with cervical cancer want to have children in the future. Currently, doctors have several fertility-preserving treatment options available, but better tools are needed to select the right treatment for each patient and to monitor for any signs of disease returning. This study aims to show how MRI imaging can make these treatment decisions more precise and help catch any problems early.
You likely qualify if…
You likely don't qualify if…
If you join the retrospective part of this study, researchers will review your past medical records and MRI images that you've already had. If you join the prospective part, you will have MRI scans before and after your fertility-sparing treatment. The study involves sharing your MRI images and tissue samples with the research team so they can analyze how well MRI predicts which patients do well with these treatments and how well the treatment works over time.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Italy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment target
~60 participants
Started
March 2024
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Benedetta Gui
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.